GT200300214A - Nuevos inhibidores biciclicos de lipasa sensible a hormonas - Google Patents

Nuevos inhibidores biciclicos de lipasa sensible a hormonas

Info

Publication number
GT200300214A
GT200300214A GT200300214A GT200300214A GT200300214A GT 200300214 A GT200300214 A GT 200300214A GT 200300214 A GT200300214 A GT 200300214A GT 200300214 A GT200300214 A GT 200300214A GT 200300214 A GT200300214 A GT 200300214A
Authority
GT
Guatemala
Prior art keywords
inhibitors
hormone
sensitive lipase
new bicycle
lipase
Prior art date
Application number
GT200300214A
Other languages
English (en)
Inventor
Dr Stefan Petry
Dr Karl-Heinz Baringhaus
Dr Norbert Tennagels
Dr Guenter Mueller
Dr Hubert Heuer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200300214A publication Critical patent/GT200300214A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS INHIBIDORES BICICLICOS DE LA LIPASA SENSIBLE A HORMONAS QUE SON DE UTILIDAD POR SU EFECTO INHIBIDOR SOBRE LA LIPASA SENSIBLE A HORMONAS Y POR LO TANTO SE FAVORECE SU USO EN CUADROS DE DIABETES MELLITUS NO INSULINO DEPENDIENTE, SINDROME DIABETICO.
GT200300214A 2002-10-12 2003-09-29 Nuevos inhibidores biciclicos de lipasa sensible a hormonas GT200300214A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10247680A DE10247680B4 (de) 2002-10-12 2002-10-12 Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase

Publications (1)

Publication Number Publication Date
GT200300214A true GT200300214A (es) 2007-02-05

Family

ID=32038583

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200300214A GT200300214A (es) 2002-10-12 2003-09-29 Nuevos inhibidores biciclicos de lipasa sensible a hormonas

Country Status (39)

Country Link
EP (1) EP1554259B1 (es)
JP (2) JP4658607B2 (es)
KR (1) KR20050059254A (es)
CN (1) CN100366616C (es)
AR (1) AR041565A1 (es)
AT (1) ATE349433T1 (es)
AU (1) AU2003275997B8 (es)
BR (1) BR0315257A (es)
CA (1) CA2501734C (es)
CR (1) CR7717A (es)
CY (1) CY1106358T1 (es)
DE (2) DE10247680B4 (es)
DK (1) DK1554259T3 (es)
EC (1) ECSP055729A (es)
ES (1) ES2277152T3 (es)
GT (1) GT200300214A (es)
HK (1) HK1080473A1 (es)
HN (1) HN2003000316A (es)
HR (1) HRP20050325A2 (es)
IL (1) IL167907A (es)
JO (1) JO2497B1 (es)
MA (1) MA27404A1 (es)
MX (1) MXPA05003359A (es)
MY (1) MY138057A (es)
NO (1) NO20052291L (es)
OA (1) OA12941A (es)
PA (1) PA8585101A1 (es)
PE (1) PE20040776A1 (es)
PL (1) PL374605A1 (es)
PT (1) PT1554259E (es)
RS (1) RS51543B (es)
RU (1) RU2325385C2 (es)
SV (1) SV2004001633A (es)
TN (1) TNSN05105A1 (es)
TW (1) TWI313265B (es)
UA (1) UA79994C2 (es)
UY (1) UY28015A1 (es)
WO (1) WO2004035550A1 (es)
ZA (1) ZA200501757B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005002130A1 (de) 2005-01-17 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005026809A1 (de) 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005026808A1 (de) 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005048897A1 (de) 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005049953A1 (de) 2005-10-19 2007-04-26 Sanofi-Aventis Deutschland Gmbh Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005049954A1 (de) * 2005-10-19 2007-05-31 Sanofi-Aventis Deutschland Gmbh Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
FR2915197B1 (fr) 2007-04-18 2009-06-12 Sanofi Aventis Sa Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
FR2915198B1 (fr) * 2007-04-18 2009-12-18 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
FR2915199B1 (fr) * 2007-04-18 2010-01-22 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
AR072707A1 (es) 2008-07-09 2010-09-15 Sanofi Aventis Compuestos heterociclicos, procesos para su preparacion, medicamentos que comprenden estos compuestos y el uso de los mismos
JP5657566B2 (ja) * 2008-12-24 2015-01-21 バイアル ポルテラ アンド シーエイ エス エイＢＩＡＬ−Ｐｏｒｔｅｌａ ＆ Ｃａ， Ｓ．Ａ． 医薬品
US8329904B2 (en) * 2009-05-12 2012-12-11 Hoffmann-La Roche Inc. Azacyclic derivatives
US8440710B2 (en) * 2009-10-15 2013-05-14 Hoffmann-La Roche Inc. HSL inhibitors useful in the treatment of diabetes
US8097634B2 (en) 2010-04-15 2012-01-17 Hoffmann-La Roche Inc. Azacyclic derivatives
US8450350B2 (en) * 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase
US8722721B2 (en) * 2011-03-16 2014-05-13 Hoffmann-La Roche Inc. SEC-hydroxycyclohexyl derivatives
US8703807B2 (en) * 2011-03-17 2014-04-22 Hoffmann-La Roche Inc. Azaspirodecanone compounds
US8809384B2 (en) * 2011-03-25 2014-08-19 Hoffmann-La Roche Inc. Azaspirodecanone compounds
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
GB201321740D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
WO2015089137A1 (en) 2013-12-11 2015-06-18 Karos Pharmaceuticals, Inc. Acylguanidines as tryptophan hydroxylase inhibitors
WO2016109501A1 (en) 2014-12-30 2016-07-07 Karos Pharmaceuticals, Inc. Amide compounds as tryptophan hydroxylase inhibitors
US9611201B2 (en) 2015-03-05 2017-04-04 Karos Pharmaceuticals, Inc. Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
JP2021535192A (ja) 2018-11-14 2021-12-16 アルタバント・サイエンシズ・ゲーエムベーハーALTAVANT SCIENCES GmbH 末梢セロトニンと関連する疾患または障害を処置するためのトリプトファンヒドロキシラーゼ１（ｔｐｈ１）の結晶性スピロ環式化合物インヒビター

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1124716A (en) * 1978-10-20 1982-06-01 Michael J. Simons Blocked benzotriazole compounds as development restrainer precursors
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
KR20030096348A (ko) * 2001-05-05 2003-12-24 스미스클라인비이참피이엘시이 Ｎ-아로일 시클릭 아민
EP1458374A2 (en) * 2001-12-14 2004-09-22 Novo Nordisk A/S Compounds and uses thereof for decreasing activity of hormone-sensitive lipase

Also Published As

Publication number Publication date
PE20040776A1 (es) 2004-12-24
MY138057A (en) 2009-04-30
RS51543B (en) 2011-06-30
EP1554259B1 (de) 2006-12-27
ES2277152T3 (es) 2007-07-01
HK1080473A1 (en) 2006-04-28
DE50306134D1 (de) 2007-02-08
DE10247680A1 (de) 2004-04-22
AU2003275997A1 (en) 2004-05-04
CN1688555A (zh) 2005-10-26
DE10247680B4 (de) 2005-09-01
CR7717A (es) 2007-09-14
CA2501734A1 (en) 2004-04-29
SV2004001633A (es) 2004-03-19
ECSP055729A (es) 2005-07-06
EP1554259A1 (de) 2005-07-20
PL374605A1 (en) 2005-10-31
AR041565A1 (es) 2005-05-18
BR0315257A (pt) 2005-08-23
MA27404A1 (fr) 2005-06-01
TW200413335A (en) 2004-08-01
WO2004035550A1 (de) 2004-04-29
JP4658607B2 (ja) 2011-03-23
UY28015A1 (es) 2004-04-30
KR20050059254A (ko) 2005-06-17
IL167907A (en) 2010-12-30
TWI313265B (en) 2009-08-11
ATE349433T1 (de) 2007-01-15
NO20052291D0 (no) 2005-05-10
JP2006509734A (ja) 2006-03-23
HN2003000316A (es) 2006-06-12
RS20050207A (en) 2007-08-03
NO20052291L (no) 2005-05-10
JO2497B1 (en) 2009-10-05
UA79994C2 (en) 2007-08-10
HRP20050325A2 (en) 2005-06-30
CN100366616C (zh) 2008-02-06
JP2011026342A (ja) 2011-02-10
OA12941A (en) 2006-10-13
PT1554259E (pt) 2007-02-28
TNSN05105A1 (en) 2007-05-14
AU2003275997B8 (en) 2010-09-30
RU2325385C2 (ru) 2008-05-27
MXPA05003359A (es) 2005-06-22
RU2005114394A (ru) 2006-01-20
AU2003275997B2 (en) 2010-03-25
CA2501734C (en) 2011-05-31
ZA200501757B (en) 2005-09-07
PA8585101A1 (es) 2004-09-16
CY1106358T1 (el) 2011-10-12
DK1554259T3 (da) 2007-05-07

Similar Documents

Publication Publication Date Title
GT200300214A (es) Nuevos inhibidores biciclicos de lipasa sensible a hormonas
NO20043486L (no) Transparent komposittsammensetning
DK1492506T3 (da) Matrix for depot-, invariant- og uafhængig-frigörelse af aktive forbindelser
BRPI0501450A (pt) Composição funcional, e, artigo
HN2003000227A (es) Inhibidores de quinasas
BR0317423A (pt) Formulário multipartes
ECSP045429A (es) Combinacion de compuestos organicos
ECSP055888A (es) Derivados de aril-quinazolin/aril-2-amino-fenil metanona que promueven la liberación de la hormona paratiroides.
RS50510B (sr) Formulacije koje sadrže ekteinascidin i disaharid
BRPI0501449A (pt) Mistura funcional, processos para curar e para curar parcialmente uma mistura funcional, e, adesivo
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
DE60213484D1 (de) Kommunikationssystem
DE60307729D1 (de) Schutzfilm
DE60306379D1 (de) Diffusionskontrolliertes wirkstoffabgabesystem mit fluorosiloxan-matrix
DE50202537D1 (de) Haftklebstoff, enthaltend Vinylpyrrolidon
DE60216645D1 (de) Antiulcus pflanzenzusammensetzung(en)
DE60217480D1 (de) 17-METHYLEN-ANDROSTAN-3a-OL-ANALOGA ALS CRH- INHIBITOREN
FR2841202B1 (fr) Dispositif de freinage de type hydraulique
GT200300027S (es) Botella.
DE502004000294D1 (de) Selbstklebende, transparente Schutzfolie
BRPI0506181A (pt) absorvente higiênico deformável
DE502007005672D1 (de) Ung
BRPI0503830A (pt) absorvente higiênico deformável
HN2002000177A (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso.
FR2841463B1 (fr) Dispositif de simulation de la marche et chaussure equipee